Global Epigenetics Market
Global Epigenetics Market is expected to be worth USD1.57 billion by 2025
Published | 28 March 2019
According to BlueWeave Consulting, The Global Epigenetics Market is expected to be worth USD1.57 billion in 2025 from USD 0.98 billion in 2018 with at a strong CAGR of 14.38% during the forecast period 2019-2025 owing to the increasing demand for epigenetics technology for curbing out cancer-related diseases.
Rapid advancements in gene technology and advantages of R&D in cost-effective & efficient for less labor-intensive will boost the Epigenetics market in the upcoming year. Moreover, the major factor driving the market growth is the growing application of epidemics in non-oncology diseases, the rise in the number of research activities, and the augmentations in collaborations between the biotechnology, academic, and pharmaceutical organizations. Furthermore, the huge increment in cancer affected patients and the extensive requirement of medical equipment in developing countries is accelerating the growth of the Epigenetics market.
Additionally, Epigenetics technology help in the fulfillment of the clinical needs of patients and help in early diagnosis of cancer diseases will contribute to Epigenetics market growth during the forecast periods. Rise in the geriatric population, and growing awareness about early diagnosis is a key driver aiding to the growth of Epigenetics Market.
The kit Product type of Epigenetics market is projected to be the leading segment of the overall market during the forecast period.
Based on product type, the Epigenetics Market segmented into Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, and Bioinformatics. Kit segment dominates the global Epigenetics owing to its ready to use & flexibility features for detecting the cancer infected diseases. Reagent will be the fastest-growing segment due to its application as primers, buffers, magnetic beads, antibodies, histones in epigenetics technology.
Oncology is projected to lead the industry to utilize applications of Epigenetics during the forecast period.
On the basis of application, the global Epigenetics market segmented into Oncology, Cardiology, and Immunology. By application type, Oncology will lead the market owing to the rise in cancer infected diseases population coupled with advancements in cancer disease detecting devices. Cardiology is expected to grow at the fastest rate during the forecast period owing to the government’s supports and huge R&D in the field of cancer-related diseases by pharmaceuticals companies.
DNA Methylation is expected to dominating technology for utilizing in Epigenetics segment during the forecast period
On the basis of Technology Type, the global Epigenetics market has been segmented into DNA Methylation, Histone Modification, and others. DNA Methylation is expected to dominate the market owing to the rise in cancer affected population coupled with its application to early detection of cancer diseases. Histone Modification market is expected to be the fastest-growing market due to its huge usage in altering chromatin structure or recruiting histone modifiers.
Asia accounts for the lion’s share of the global Epigenetics market during the anticipated period.
Based on the region, the Epigenetics market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominates the global Epigenetics market over the forecast period owing to government encouragement through financial aid, rises in the geriatric population, and high awareness for technological advancements in genetic disease. The Asia Pacific is estimated to witness the fastest growing market over the forecast period owing to augmentation in R&D infrastructure, encouragement by government initiatives, and diversified healthcare market.
Global Epigenetics Market Competitive Landscape
Companies, such as Illumina, Diagenode, QIAGEN, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, PerkinElmer, Bio-Rad Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., and Novartis AG are the key players in the manufacturing of Epigenetics products.
Explore full report with detailed TOC, “Global Epigenetics Market, By Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), By Region (North America, Europe, Asia Pacific, Middle East & Africa And Latin America), Growth Potential, Trends Analysis, Competitive Market Size And Forecast, 2019-2025” at https://www.blueweaveconsulting.com/report/global-epigenetics-market-bwc19118
The in-depth analysis of the report provides the growth potential, upcoming trends, and statistics of Global Epigenetics Market size & forecast. The report promises to provide state-of-the-art technology of Epigenetics production and industry insights, which help decision-makers to make sound strategic decisions. Furthermore, the report also analyzes the market drivers and challenges and competitive analysis of the market.
- Global Epigenetics Market, By Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), By Region (North America, Europe, Asia Pacific, Middle East & Africa And Latin America), Growth Potential, Trends Analysis, Competitive Market Size And Forecast, 2019-2025
Publish Date: March 2019
Relevant Press Releases
- Global Wearable Robotic Exoskeleton Market Size Expanding More Than 13X to Reach USD 17.2 Billion by 2028
- Saudi Arabia Medical Gloves Market to Witness 9.4% CAGR During 2022-2028
- India Face Mask Market to Continue Witnessing Double Digit Growth during through 2028
- United States Dry Mouth Relief Consumption Market Size Expanding at Steady CAGR of 7.04% between 2023 and 2029
- Saudi Arabia Digital Pathology Market to Grow at 11.5 percent CAGR